Evalution of Programmed Cell Death 4 (PDCD4) Expression in Patients with Acute Myeloid Leukemia
Background: Acute myeloid leukemia (AML) is clinically, cytogenetically, and molecularly heterogeneous. Advances in molecular research have greatly improved our understanding of the leukemogenesis in AML. Programmed cell death-4 (PDCD4) is a novel tumor suppressor that inhibits neoplastic transforma...
Main Authors: | Mojtaba Ali Akbarpouranzab, Shahrbanoo Rostami, Kamran Ali Moghaddam, Fatemeh Nadali |
---|---|
Format: | Article |
Language: | fas |
Published: |
Isfahan University of Medical Sciences
2013-08-01
|
Series: | مجله دانشکده پزشکی اصفهان |
Subjects: | |
Online Access: | http://jims.mui.ac.ir/index.php/jims/article/view/2696 |
Similar Items
-
Myeloid-derived suppressor cells in Chronic myeloid leukemia
by: Cesarina eGiallongo, et al.
Published: (2015-05-01) -
ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia
by: Ran Li, et al.
Published: (2022-08-01) -
Monocytic Myeloid-Derived Suppressor Cells But Not Monocytes Predict Poor Prognosis of Acute Myeloid Leukemia
by: Xiyang Ren, et al.
Published: (2022-11-01) -
Aberrant Methylation of APAF-1 Gene in Acute Myeloid Leukemia Patients
by: Shahrbano Rostami, et al.
Published: (2016-12-01) -
Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia with NPM1 Marker
by: Nasrin Alizad Ghandforoush, et al.
Published: (2016-06-01)